(NYSE: TMO) Thermo Fisher Scientific's forecast annual revenue growth rate of 5.09% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 7.73%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.54%.
Thermo Fisher Scientific's revenue in 2026 is $46,336,000,000.On average, 31 Wall Street analysts forecast TMO's revenue for 2026 to be $17,876,541,783,528, with the lowest TMO revenue forecast at $17,279,030,169,352, and the highest TMO revenue forecast at $18,722,153,826,610. On average, 31 Wall Street analysts forecast TMO's revenue for 2027 to be $18,810,153,680,678, with the lowest TMO revenue forecast at $18,081,012,032,686, and the highest TMO revenue forecast at $20,107,596,907,252.
In 2028, TMO is forecast to generate $19,921,244,275,108 in revenue, with the lowest revenue forecast at $19,050,489,416,578 and the highest revenue forecast at $21,262,687,428,716.